Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T18:47:14.789Z.
Calculation as of: 2026-10-06T18:47:14.789Z.
Quote observation: 2026-10-06T18:43:51.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1ca0602d484fef860d1886a06048f849113dfee726f77a026e2ec96edb2346c6
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2015-05-11.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
FREE CASH FLOW YIELD AVG TTM
N/A
FREE CASH FLOW YIELD AVG 3Y
N/A
FREE CASH FLOW YIELD AVG 5Y
N/A
FREE CASH FLOW YIELD AVG 10Y
N/A
FREE CASH FLOW YIELD AVG 15Y
N/A
FREE CASH FLOW YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$82.47M
Free Cash Flow Yield
N/A
TTM Avg
5.92%
3Y Avg
6.70%
5Y Avg
6.29%
Market Cap
$83.00M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$83.65M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$83.69M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$80.81M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MediciNova, Inc. (MNOV) | $82.45M | N/A | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA)vs › | $82.39M | N/A | N/A | N/A | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $82.47M | N/A | 5.92% | 6.70% | 6.29% |
| LENSAR Inc (LNSR)vs › | $83.02M | N/A | N/A | N/A | N/A |
| ProMIS Neurosciences, Inc. (PMN)vs › | $83.00M | N/A | N/A | N/A | N/A |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $83.65M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $83.69M | N/A | N/A | N/A | N/A |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs › | $80.81M | N/A | N/A | N/A | N/A |
| Nutriband Inc. (NTRB)vs › | $80.53M | N/A | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $80.90M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | FREE CASH FLOW YIELD |
|---|---|
| 2015-05-11 | 0.82% |
| 2015-05-08 | 0.82% |
| 2015-05-07 | 0.82% |
| 2015-05-06 | 0.80% |
| 2015-05-05 | 0.82% |
| 2015-05-04 | 0.84% |
| 2015-05-01 | 0.86% |
| 2015-04-30 | 0.85% |
| 2015-04-29 | 0.88% |
| 2015-04-28 | 0.86% |
| 2015-04-27 | 0.88% |
| 2015-04-24 | 0.81% |
| 2015-04-23 | 0.83% |
| 2015-04-22 | 0.83% |
| 2015-04-21 | 0.81% |
| 2015-04-20 | 0.81% |
| 2015-04-17 | 0.74% |
| 2015-04-16 | 0.67% |
| 2015-04-15 | 0.94% |
| 2015-04-14 | 0.95% |
| 2015-04-13 | 0.98% |
| 2015-04-10 | 0.95% |
| 2015-04-09 | 0.97% |
| 2015-04-08 | 0.95% |
| 2015-04-07 | 0.99% |
| 2015-04-06 | 0.97% |
| 2015-04-02 | 0.96% |
| 2015-04-01 | 0.93% |
| 2015-03-31 | 0.94% |
| 2015-03-30 | 0.92% |
| 2015-03-27 | 0.93% |
| 2015-03-26 | 0.99% |
| 2015-03-25 | 1.01% |
| 2015-03-24 | 0.97% |
| 2015-03-23 | 0.97% |
| 2015-03-20 | 0.93% |
| 2015-03-19 | 0.93% |
| 2015-03-18 | 0.96% |
| 2015-03-17 | 1.01% |
| 2015-03-16 | 1.02% |
| 2015-03-13 | 0.98% |
